United Kingdom · Question · Written question
UIN 3577
Lumacaftor/ivacaftor
Original
Introduced
22 October 2019
Last action
30 October 2019 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 October 2019
Summary
To ask the Secretary of State for Health and Social Care, what recent progress his Department has made on negotiations between NHS England and Vertex pharmaceuticals on making Orkambi available on the NHS for people diagnosed with cystic fibrosis.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 October 2019
Written question
To ask the Secretary of State for Health and Social Care, what recent progress his Department has made on negotiations between NHS England and Vertex pharmaceuticals on making Orkambi available on the NHS for people diagnosed with cystic fibrosis.
Source: Commons
30 October 2019
Answer
On 24 October, NHS England and NHS Improvement announced that a deal had been agreed with the company Vertex to make Orkambi and its other licensed cystic fibrosis drugs available to National Health Service patients in England. This deal, while commercial...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2019-10-22/3577
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1151322
- uk · wq-1151322 · source updated 30 October 2019